MASLD epidemiology, natural history and diagnosis
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of chronic liver disease worldwide, with an estimated prevalence of 38%. Its burden varies considerably across regions, populations and demographic groups, influenced by genetic, biological, environmental and social factors. T...